A case report of remarkable response to association of radiofrequency ablation with subsequent Atezolizumab in stage IV nonsmall cell lung cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference28 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010
3. Osimertinib as first-line treatment in EGFR-mutated non-small-cell lung cancer;Popat;N Engl J Med,2018
4. Targeting immune checkpoints in non small cell lung cancer;Bianco;Curr Opin Pharmacol,2018
5. Role of immune-checkpoint inhibitors in lung cancer;Jain;Ther Adv Respir Dis,2018
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Microwave ablation enhances the systemic immune response in patients with lung cancer;Oncology Letters;2024-01-18
2. Potential of Thermal Ablation Combined with Immunotherapy in Peripheral Lung Tumors: A Review and Prospect;Respiration;2024
3. Radiofrequency ablation for stage <IIB non‐small cell lung cancer: Opportunities, challenges, and the road ahead;Thoracic Cancer;2023-09-23
4. Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy;Frontiers in Immunology;2022-09-29
5. Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy;Frontiers in Immunology;2022-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3